5-fluorouracil induces apoptotic cell death with G2 phase arrest in human breast cancer grafted in nude mice

Anticancer Research

Volumn 16, Issue 5 A, 1996, Pages 2699-2704

  Okamoto, Shigeru ^a   Sakai, Masahide ^a   Uchida, Junji ^b   Saito, Hitoshi ^b  

^a Osaka Teishin Hospital   (Japan)

^b TAIHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

5 Fluorouracil; Apoptosis; Flow cytometry; G2 arrest

Indexed keywords

FLUOROURACIL; MONOCLONAL ANTIBODY KI 67; PROPIDIUM IODIDE; TEGAFUR; UFT;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER INHIBITION; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL DEATH; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MITOSIS RATE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; BODY WEIGHT; BREAST NEOPLASMS; CELL DEATH; DNA, NEOPLASM; FEMALE; FLOW CYTOMETRY; FLUOROURACIL; HUMANS; INTERPHASE; MICE; MICE, INBRED BALB C; MICE, NUDE; TRANSPLANTATION, HETEROLOGOUS;

EID: 0029958350     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Meyers CE.: The pharmacology of the fluoropyrimidines. Pharmacol Rev 33: 1-15, 1981.
2. Kufe DW, Major PD: 5-fluorouracil incorporation into breast carcinoma. RNA correlates with cytotoxicity. J Biol Chem 256: 9802-9810, 1981.
3. Yushioka A, Tanaka S, Hiraoka O, Koyama Y, Hirota Y, Ayusawa D, Seno T, Garrett C, Wataya Y: Deoxyrihonuclcosidc triphosphate imbalance: 5-Fluorodeoxyuridine-induced DNA double strand breaks in mouse FM3A cells and the mechanism of cell death. J Biol Chem 262: 8235-8241, 1987.
4. Lewin F, Skong S, Tribukait B, Ringborg U.: Effect of 5-fluorouracil on the cell growth and cell cycle kinetics of a mouse ascites growing in vivo. Acta Oncologica 26: 125-131, 1987.
5. Ijiri K, Potten CS: Further studies on the response of intestinal crypt cells of different hierarchical status to eighteen different cytotoxic agents. Br J Cancer 55: 113-123, 1987.
6. Lee FD: Importance of apoptosis in the histopathology of drug related lesions in the large intestine. J Clin Pathol 46: 118-122, 1993.
7. Sakaguchi Y, Stephens LC, Makino M, Kaneko T, Strebel FR, Danhauser LL, Jenkins G, Bulli JMC: Apoptosis in normal tissues induced by 5-fluorouracil: comparison between bolus injection and prolonged infusion. Anticancer Res 14: 1489-1492, 1994.
8. Sorenson CM, Barry MA, Eastman A: Analysis of events associated with cell cycle arrest at G2 phase and cell death induced by cisplatin. J Natl Cancer Inst 82: 749-755, 1990.
9. Eastman A: Activation of programmed cell death by anticancer agents: cisplatin as a model system. Cancer Cells 2: 275-280, 1990.
10. Shchepotin IB, Soldatenkov V, Buras RR, Nauta RJ, Shabahang M, Evans SRT: Apoptosis of human primary and metastatic colon adenocarcinoma cell lines in vitro induced by 5-fluorouracil, verapamil, and hyperthermia. Anticancer Res 14: 1027-1032, 1994.
11. Wyllie AH, Kerr JFR, Currie AR: Cell death: The significance of apoptosis. Int Rev Cytol 68: 251-306, 1980.
12. Kerr JFR, Harmon BV: Definition and incidence of apoptosis: An historical perspective. In Apoptosis: The Molecular Basis of Cell Death (edited by Tomei, LD and Cope FO), p5-29, Cold Spring Harbor Laboratory Press, 1991.
13. Schwartzman RA, Cidlowski JA: Apoptosis: the biochemistry and molecular biology of programmed cell death. Endocrinol Rev 14(2): 133-151, 1993.
14. Smets LA: Programmed cell death (apoptosis) and response to anti-cancer drugs. Anti-Cancer Drugs 5: 3-9, 1994.
15. Fujii S, Ikenaka K, Fukushima M, Shirasaka T: Effect of uracil and its derivatives on antitumor activity of 5-fluorouracil and 1-(2-tetrahydrofuryl)-5-fluorouracil. Gann 69: 763-772, 1978.
16. Ota K, Taguchi T, Kimura K.: Report on nationwide pooled data and cohort investigation in UFT phase II study. Cancer Chemother Pharmacol 22: 333-338, 1988.
17. Malik STA, Tablot D, Clarke PI, Osborne R, Reznek R, Wrigley PF, Slevin ML: Phase II trial of UFT in advanced colorectal and gastric cancer. Br J Cancer 62: 1023-1025, 1990.
18. Kobayashi T, Yayoi E, Takatsuka Y, Maeura Y, Furukawa J, Kitada M, Okamoto S: Use of flow cytometry for evaluating breast cancer cell proliferation after chemotherapy. Current Therapeutic Research 56: 769-776, 1995.
19. Hanaue H, Kurosawa T, Kitano Y, Miyakawa S, Nemoto A, Yamamoto H, Asagoe T, Takada T, Yasuda H, Shikata J: Anticancer drug distribution in lymph and blood during adjuvant chemotherapy after surgery for gastric carcinoma. Cancer 59: 1571-1576, 1987.
20. Vindeløv LL, Christensen IJ, Nissen NI: A detergent-trypsin method for the preparation of nuclei for flow cytometric analysis. Cytometry 3: 323-327, 1983.
21. Landberg G, Tan EME, Roos G: Flow cytometric multiparameter analysis of proliferating cell nuclear antigen/cyclin and Ki-67 antigen: A new view of the cell cycle. Exp Cell Res 187: 111-118, 1990.
22. Gerdes J, Schwab U, Lemke H, Stein H: Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 31: 13-20, 1983.
23. Gerdes J, Lemke H, Baisch H, Wecker HH, Schwab U, Stein H: Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133: 1710-1715, 1984.
24. Kaufmann SH: Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etopside. camptothecin, and other cytotoxic anticancer drugs: a cautionary note. Cancer Res 49: 5870-5878, 1989.
25. Arends MJ, Morris RG, Wyllie AH.: Apoptosis: The role of the endonuclease. Am J Pathol 136: 593-608, 1990.
26. Smets LA, Bout B, Brouwer M, Tulp A: Cytotoxic effects of dexamethasone restricted to non-cycling, early G1 phase cells of L1210 leukemia. J Cell Physiol 116: 397-403, 1983.
27. Kyprianou N, English HF, Isaacs JT: Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation. Cancer Res 50: 3748-3753, 1990.
28. Shaw P, Bovey R, Tardy S, Sahli R, Sordat B, Costa J: Induction of apoptosis by wild-type p53 in human colon tumor-derived cell line. Proc Natl Acad Sci USA 89: 4495-4499, 1992.
29. Smith C, Williams G, Kingston R, Jenkinson EJ, Owen JJ: Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature 337: 181-184, 1989.